This move is archived. Current quotes and coverage live on the stock page.
Follow APLI
A remarkable 50% jump in Appili Therapeutics Inc's stock price has caught the attention of investors.
Appili Therapeutics Inc (APLI.TO) experienced a significant surge in its stock price yesterday, closing up 50% at CA$0.01. This notable increase has raised eyebrows among investors, especially given the company's recent challenges and limited media coverage.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$661,830
52W high
$0.03
52W low
$0.01
1W change
-50.00%
Beta
-0.19
Analyst Price Targets
Based on analyst covering APLI · as of Sep 17, 2026
Wall Street analysts forecast APLI stock price to rise 2900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+2900.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
473.3%
Annualized
90-Day Vol
313.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.00 | C$0.00 – C$0.02 |
| 60 trading days | C$0.00 | C$0.00 – C$0.04 |
| 90 trading days | C$0.00 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the volatility and potential risks associated with Appili Therapeutics, particularly in light of its recent operational shifts and the uncertain outlook for its programs.
Appili Therapeutics Inc stock up 50%
The stock's price increase reflects a significant turnaround, but investors should remain cautious due to the company's financial instability and lack of recent positive news.
Bull case
The sharp increase in stock price may signal renewed investor interest or optimism about future developments in Appili's programs, especially in biodefense and health-security initiatives.
Bear case
Despite the surge, Appili's market cap remains low at CA$1,985,491, and the company has faced operational challenges, including a recent termination notice from NIAID regarding its VXV-01 program.
Market Reaction to Appili's Surge
Advertisement
The 50% increase in Appili's stock price yesterday has sparked discussions among investors about the potential for recovery and growth. Given the company's recent strategic shift towards biodefense, there may be a renewed sense of optimism in the market. However, investors should be wary of the stock's volatility and the underlying challenges the company faces.
Understanding Appili's Recent Developments
Appili Therapeutics has been navigating a complex landscape, particularly after receiving a termination notice from NIAID regarding its VXV-01 program. This development raises questions about the company's future direction and its ability to capitalize on new opportunities in the health sector. Investors should stay informed about any forthcoming announcements that could impact the stock's trajectory.
What’s Next for Investors?
With a market cap of just under CA$2 million, Appili remains a speculative investment. Investors should consider their risk tolerance and the potential for further volatility in the stock price. Keeping an eye on the company's operational updates and market sentiment will be crucial for making informed investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
